8/21/2019 DAFTAR PUSTAKA Vancouver Kanker Paru

1/3

DAFTAR PUSTAKA

1. Byrne TN. Spinal cord compression from epidural metastases. N Eng J Med 1992;327(9): 614-9.

2. Helweg-Larsen S, Sorensen PS. Symptoms and signs in metastatic spinal cordcompression: a study of progression from first symptom until diagnosis in 153 patients.

Eur Jour Cancer 1994;30A(3): 396-8.

3. Turner S, Marosszeky B, Timms I, Boyages J. Malignant spinal cord compression: aprospective evaluation. Int. J. Radiation Oncology Biol. Phys. 1993;26: 141-6.

4. Alberg AJ, Ford JG, Samet JM: Epidemiology of lung cancer. ACCP evidence-basedclinical practice guidelines, 2nd ed, Chest 2007; 132:2955.

5. Alberts WM: Diagnosis and management of lung cancer executive summary: ACCPevidence-based clinical practice guidelines, 2nd ed, Chest 132: 1S19S, 2007.

6. Bach PB, Silvestri GA, Hanger M, Jett JR: Screening for lung cancer: ACCP evidence-based clinical practice guidelines, 2nd ed, Chest 132: 69S77S, 2007.

7. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatictumor: diagnosis and treatment. Ann Neurol 1978;3:40-51.

8. Stark RJ, Henson RA, Evans SJW. Spinal metastases: a retrospective survey from ageneral hospital. Brain 1982; 105:189-213.

9. Desforges, 199210.Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied

cases. Cancer 1950; 3:74-85

11.Arguello F, Baggs RB, Duerst RE, Johnstone L, McQueen K, Frantz CN. Pathogenesis ofvertebral metastasis and epidural spinal cord compression. Cancer 1990;65: 98-106.

12.Batson OV. The function of the vertebral veins and their role in the spread of metastases.Ann Surg 1940; 112-138-49.

13.Tancioni F, Navarria P, Lorenzetti MA, et al. Multimodal approach to the management ofmetastatic epidural spinal cord compression (MESCC) due to solid tumors. Int J.

Radiation Oncology Biol Phys. 2010;78(5):1467-73.

8/21/2019 DAFTAR PUSTAKA Vancouver Kanker Paru

2/3

14.Redmond J III, Friedl KE, Cornett P, Stone M, ORourke T, George CB. Clinicalusefulness of an algorithm for the early diagnosis of spinal metastatic disease. J Clin

Oncol 1988;6:154-157.

15.Patchell RA, Tibbs PA, Regine WF. Direct decompressive surgical resection in thetreatment of spinal cord compression caused by metastatic cancer: a randomised trial.

Lancet 2005; 366: 643-8.

16.Dhala A, Pinsker K, Prezant DJ: Respiratory health consequences of environmentaltobacco smoke, Med Clin North Am 2004; 88:15351552.

17.Denissenko MF, Pao A, Tang M, Pfeifer GP: Preferential formation of benzo[a]pyreneadducts at lung cancer mutational hotspots in p53, Science 1996; 274:430432.

18.Subramanian J, Govindan R: Lung cancer in never smokers: a review, J Clin Oncol25:561570, 2007.

19.Goodman GE: Prevention of lung cancer, Thorax 2000; 57:99499920.Whitesell PL, Drage CW: Occupational lung cancer, Mayo Clin Proc 68:183188, 1993.21.Rom WN, Hay JG, Lee TC, Jiang Y, Tchou-Wong KM: Molecular and genetic aspects of

lung cancer, Am J Respir Crit Care Med 161:13551367, 2000.

22.Sato M, Shames DS, Gazdar AF, Minna JD: A translational view of the molecularpathogenesis of lung cancer, J Thorac Oncol 2:327343, 2007.

23.Field RW, Krewski D, Lubin JH, et al: An overview of the North American residentialradon and lung cancer case-control studies, J Toxicol Environ Health A 2006; 69:599

631.

24.Miller YE: Pathogenesis of lung cancer. 100 year report, Am J Respir Cell Mol Biol33:216223, 2005.

25.Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y: The new World HealthOrganization classifi cation of lung tumors, Eur Respir J 18:10591068, 2001.

26.Schwartz AM, Henson DE: Diagnostic surgical pathology in lung cancer. ACCPevidence-based clinical practice guidelines, 2nd ed, Chest 132:78S93S, 2007.

27.Franklin WA: Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia,Chest 117(suppl):80S89S, 2000.

28.Mller K-M: Lung cancer: morphology, Eur Respir Mon 17:3447, 2001.29.Travis WD: Pathology of lung cancer, Clin Chest Med 23:6581, 2002.

8/21/2019 DAFTAR PUSTAKA Vancouver Kanker Paru

3/3

30.Mulshine JL, Sullivan DC: Clinical practice. Lung cancer screening, N Engl J Med 2005;352:27142720.

31.Boiselle PM, Ernst A, Karp DD: Lung cancer detection in the 21st century: potentialcontributions and challenges of emerging technologies, AJR Am J Roentgenol 2000;

175:12151221

32.Pieterman RM, van Putten JW, Meuzelaar JJ, et al: Preoperative staging of non-small-celllung cancer with positron-emission tomography, N Engl J Med 2000; 343:254261.

33.Birim O, Kappetein AP, Stijnen T, Bogers AJ: Meta-analysis of positron emissiontomographic and computed tomographic imaging in detecting mediastinal lymph node

metastases in nonsmall cell lung cancer, Ann Thorac Surg 79:375382, 2005.

34.. Silvestri GA, Gould MK, Margolis ML, et al: Noninvasive staging of small cell lungcancer: ACCP evidence-based clinical practice guidelines, 2nd ed, Chest 2007; 132:

178S201S.

35.Hollings N, Shaw P: Diagnostic imaging of lung cancer, Eur Respir J 2002; 19:722742.36.Krupnick AS, Kreisel D, Hope A, Bradley J, Govindan R, Meyers B: Recent advances

and future perspectives in the management of lung cancer, Curr Probl Surg 2005;

42:540610.

37.Mazzone PJ, Arroliga AC: Lung cancer: preoperative pulmonary evaluation of the lungresection candidate, Am J Med 2005; 118:578583.

38.Spiro SG, Porter JC: Lung cancerwhere are we today? Current advances in staging andnonsurgical treatment, Am J Respir Crit Care Med 2002; 166:11661196.

39.Visbal AL, Leighl NB, Feld R, Shepherd FA: Adjuvant chemotherapy for early-stagenon-small cell lung cancer, Chest 2005; 128:29332943.

40.Spira A, Ettinger DS: Multidisciplinary management of lung cancer, N Engl J Med 2004;350:379392.